Patents Assigned to FRONTHERA U.S. PHARMACEUTICALS LLC
  • Hemoglobin modifier compounds and uses thereof
    Patent number: 10787430
    Abstract: Described herein are compounds, including pharmaceutically acceptable salts thereof, methods of making such compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat, prevent or diagnose blood-based diseases, disorders or conditions.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: September 29, 2020
    Assignee: FRONTHERA U.S. PHARMACEUTICALS LLC
    Inventors: Bohan Jin, Qing Dong, Gene Hung
  • Autotaxin inhibitors and uses thereof
    Patent number: 10711000
    Abstract: Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: July 14, 2020
    Assignee: FRONTHERA U.S. PHARMACEUTICALS LLC
    Inventors: Bohan Jin, Qing Dong, Gene Hung, Yao Li